RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 VLTS-394 Ineffective in the Treatment of Intermittent Claudication
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 5
SP 14
OP 14
DO 10.1177/155989770600600505
UL http://mdc.sagepub.com/content/6/5/14.abstract
AB Patients with peripheral artery disease often experience difficulty walking and painful cramps because of the narrowing of arteries in the legs. This painful condition, known as intermittent claudication (IC), can range in severity from being mildly irritating to extremely debilitating. The efficacy and safety of VLTS-934, a compound believed to increase microvascular blood flow, was evaluated in a Phase 2b randomized, double-blind, placebo-controlled multicenter trial of patients with IC conducted in the United States.